A Randomized, Double-Blind, Controlled Clinical Trial of Omega-3 Fatty Acids and Inositol as Monotherapies and in Combination for the Treatment of Pediatric Bipolar Spectrum Disorder in Children Age 5-12.
- DOI
- 10.64719/pb.4449
- Published
- 2022 Oct 27
- Container
- Psychopharmacology bulletin
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.64719/pb.4449,
title = {A Randomized, Double-Blind, Controlled Clinical Trial of Omega-3 Fatty Acids and Inositol as Monotherapies and in Combination for the Treatment of Pediatric Bipolar Spectrum Disorder in Children Age 5-12.},
author = {Wozniak J and Farrell A and DiSalvo M and Ceranoglu A and Uchida M and Vaudreuil C and Joshi G and Faraone SV and Cook E and Biederman J},
year = {2022},
journal = {Psychopharmacology bulletin},
doi = {10.64719/pb.4449},
url = {https://doi.org/10.64719/pb.4449}
}RIS
TY - JOUR TI - A Randomized, Double-Blind, Controlled Clinical Trial of Omega-3 Fatty Acids and Inositol as Monotherapies and in Combination for the Treatment of Pediatric Bipolar Spectrum Disorder in Children Age 5-12. AU - Wozniak J AU - Farrell A AU - DiSalvo M AU - Ceranoglu A AU - Uchida M AU - Vaudreuil C AU - Joshi G AU - Faraone SV AU - Cook E AU - Biederman J PY - 2022 JO - Psychopharmacology bulletin DO - 10.64719/pb.4449 UR - https://doi.org/10.64719/pb.4449 ER -
APA
J, W., A, F., M, D., A, C., M, U., C, V., G, J., SV, F., E, C., & J, B. (2022). A Randomized, Double-Blind, Controlled Clinical Trial of Omega-3 Fatty Acids and Inositol as Monotherapies and in Combination for the Treatment of Pediatric Bipolar Spectrum Disorder in Children Age 5-12.. Psychopharmacology bulletin. https://doi.org/10.64719/pb.4449
Source records
- pubmed · retrieved 2026-09-26T08:51:03.211Z